New health concerns about 'fake pot' in US

A type of fake pot has raised new health concerns in the United States after at least three users were hospitalized for kidney failure, authorities in the western state of Wyoming said Monday.

Often known as "Spice" or "K2," the substance is marketed to young people as herbal incense, and creates a marijuana-like high when it is smoked like a joint or a cigarette.

"At this point we are viewing use of this drug as a potentially life-threatening situation," Tracy Murphy, state epidemiologist with the Wyoming Department of , said in a statement sent to AFP.

State health authorities first learned of the latest incidents on Thursday involving three patients in central Wyoming who sought hospital care after smoking a product known as "blueberry spice," a spokeswoman added.

There have been no deaths and no reports of connected cases in other areas, she added.

However, drug say that fake pot use has been on the rise in recent years, ever since it was first copied from a US scientist's lab research in the mid 1990s and quickly spread around the world.

The compound, known as JWH-018, was created in the lab of John Huffman, a professor of at Clemson University, who was researching how marijuana-like compounds act on .

According to the US Drug Enforcement Agency, which in 2011 banned JWH-018 and four other synthetic , calls to poison control centers rose from just over 100 in 2009 to more than 2,700 nationwide in the space of a year.

"Technically it is an incense, it is not for , you know what I am saying?" said a smoke shop owner in Arizona who asked not to be named.

He said he continues to stock three kinds of herbal incense, but none that carry ingredients outlawed by the DEA.

"If there is a banned substance in there, then we don't have it in our store," he told AFP by phone, adding that brands and popularity change frequently.

"You know, people go from their K2 to their Dead Man Walking, to their Smoking Camel, there is all kinds of stuff out there," he said.

"I'll be happy when it's gone."

add to favorites email to friend print save as pdf

Related Stories

US bans 'fake' marijuana chemicals

Nov 24, 2010

US authorities slapped a temporary ban Wednesday on chemicals used to make so-called "fake marijuana" that has been used as a legal alternative to pot.

SLU toxicologist warning to parents: Look for signs of K2

Mar 03, 2010

In the last month, Anthony Scalzo, M.D., professor of toxicology at Saint Louis University, has seen nearly 30 cases involving teenagers who were experiencing hallucinations, severe agitation, elevated heart rate and blood ...

Survey: Teen pot use rises, alcohol use declines

Dec 14, 2011

(AP) -- More teens are turning to pot and see it as less of a risk at the same time alcohol use among the same age group has dipped to historic lows, according to an annual national survey of drug use released Wednesday.

Synthetic drugs send thousands to ER

Apr 07, 2011

(AP) -- Until he tried a marijuana look-alike product called "K2," David Rozga's most dubious decision was getting a Green Bay Packers tattoo on his shoulder.

Recommended for you

FDA approves hard-to-abuse narcotic painkiller

Jul 25, 2014

(HealthDay)—A new formulation of a powerful narcotic painkiller that discourages potential abusers from snorting or injecting the drug has been approved by the U.S. Food and Drug Administration.

Race affects opioid selection for cancer pain

Jul 25, 2014

(HealthDay)—Racial disparities exist in the type of opioid prescribed for cancer pain, according to a study published online July 21 in the Journal of Clinical Oncology.

FDA approves tough-to-abuse formulation of oxycodone

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe ...

Tough-to-abuse formulation of oxycodone approved

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe pain when other ...

EU regulator: Morning-after pill OK for all women

Jul 24, 2014

(AP)—A commonly used morning-after pill is suitable for use by heavier women, the European Medicines Agency said Thursday after a review of the evidence sparked by the French manufacturer's declaration that the drugs didn't ...

User comments